Millions Of Doses Of Serum's Covid-19 Vaccine Clear Quality Test At Govt's Lab; Ready For Roll-Out Upon Clearance

In a positive development for India's fight against the Covid-19 pandemic, millions of doses of the Covishield vaccine, which is being manufactured by the Pune based Serum Institute of India (SII), have passed the quality test at the government's laboratory for testing vaccines, reports Economic Times.

As many as 25 million doses of the Covishield vaccine are said to have been tested for quality at the Kasauli based Central Drug Laboratory (CDL). Now, these doses can be rolled out for administration as soon as Covishield is approved and cleared by the Drugs Controller General of India (DCGI).

Covishield vaccine has been developed by the University of Oxford in association with pharmaceutical major AstraZeneca. The said vaccine is currently undergoing Phase-III clinical trials in India and SII has already applied for an emergency use authorisation (EUA) of the same.

Led by Adar Poonawalla, SII, which is the world's largest vaccine manufacturer in term of doses, has already begun stockpiling doses of Covishield which can be rolled out once it is approved for administration in the nation. Recently, Prime Minister (PM) Narendra Modi had also visited the company's campus in Pune to review the progress of vaccine development.